अApnaFunda
Menu

LOTUS EYE HOSPITAL AND INS LTD (LOTUSEYE)

Health Services

Quality scoreHow the business itself ranks against its sector peers on profitability, 3-year growth and leverage. 50 is the middle of the sector.32 / 100
Profitability 16Growth 13Balance sheet 69
Compare withDR. LAL PATHLABS LIMITEDVIJAYA DIAGNOSTIC CENTRE LTDMETROPOLIS HEALTHCARE LIMITED
Share Price
₹109.15
P/E
1559.3x
ROCE
1.4%
Market Cap
₹227 cr
Revenue (TTM)
₹57 cr
P/S
4.0x
P/B
3.8x
ROE
0.2%
Operating Margin
17.3%
Debt / Equity
0.3x
Promoter Holding
40.1%
12M Momentum
-12.7%
P/E vs its own history96th percentilesince Jan '19
P/E vs Health Services33.6xthe sector median

52-week range

₹97.59₹147.00
23% of the way from its 52-week low to its high

Price risk

1Y volatility
44.8%
Beta vs sector
1-year daily
0.30

Balance sheet & cash

Interest cover
operating profit ÷ interest
1.2x
Cash from profit, 3Y
operating cash flow ÷ net profit
3.06x
Share count, 1Y
unchanged

Was the rally earned?

-13%share price, 1 yearEarnings-driven

Mostly earnings.

  • Per-share earnings took off 139 points, while the multiple moved less (P/E 403.3x to 1559.3x).
  • The share count barely moved.
1 year Net profit growth: -139 pts. Points of the price return explained by net profit growing (or shrinking).-139 ptsP/E change: +126 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+126 pts -13% 1 year Net profit growth: -139 pts. Points of the price return explained by net profit growing (or shrinking).-139 ptsP/E change: +126 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+126 pts -13%
Net profit growth-139 ptsNet profit fell about 77%, which lowers the price.
P/E change+126 ptsThe P/E rose from 403.3x to 1559.3x, which lifts the price.
Share count change0 ptsShare count was little changed. More shares would count against the price.
+34%share price, 3 yearsMultiple-driven

Partly.

  • Most of the rise came from investors paying a higher multiple (P/E 41.6x to 1559.3x); per-share earnings took off 387 points.
  • The share count barely moved.
3 years Net profit growth: -387 pts. Points of the price return explained by net profit growing (or shrinking).-387 ptsP/E change: +421 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+421 pts +34% 3 years Net profit growth: -387 pts. Points of the price return explained by net profit growing (or shrinking).-387 ptsP/E change: +421 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+421 pts +34%
Net profit growth-387 ptsNet profit fell about 96%, which lowers the price.
P/E change+421 ptsThe P/E rose from 41.6x to 1559.3x, which lifts the price.
Share count change0 ptsShare count was little changed. More shares would count against the price.
+172%share price, 5 yearsMultiple-driven

Partly.

  • Most of the rise came from investors paying a higher multiple (P/E 53.5x to 1559.3x); per-share earnings took off 407 points.
  • The share count barely moved.
5 years Net profit growth: -408 pts. Points of the price return explained by net profit growing (or shrinking).-408 ptsP/E change: +579 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+579 pts +172% 5 years Net profit growth: -408 pts. Points of the price return explained by net profit growing (or shrinking).-408 ptsP/E change: +579 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.+579 pts +172%
Net profit growth-407 ptsNet profit fell about 91%, which lowers the price.
P/E change+579 ptsThe P/E rose from 53.5x to 1559.3x, which lifts the price.
Share count change0 ptsShare count was little changed. More shares would count against the price.
What do "pts" mean?

"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.

Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.

Net profit is trailing twelve months as reported with a 60-day lag.

Compare this with DR. LAL PATHLABS

Is it expensive against its own past and its peers?

1559.3xP/E todayNear its historic high
Against its own history96th percentileMedian 65.1x; usual range 38.7x to 365.9x since 2019-01.
Against Health Services1559.3x vs 46.4xAbove the Health Services median.
23.2x994.7x1966.2x2937.8xJan '19Aug '20Mar '22Oct '23May '25Oct '2623.2x994.7x1966.2x2937.8xJan '19Aug '21Mar '24Oct '26
P/E (this company)10th to 90th percentile of its own historyIts medianHealth Services median

The chart loads when you open this tab.

P/B (this company)10th to 90th percentile of its own historyIts medianHealth Services median

The chart loads when you open this tab.

P/S (this company)10th to 90th percentile of its own historyIts medianHealth Services median
How to read this

Shaded band: 10th to 90th percentile of the company's own P/E history; dashed line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).

Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.

All terms explained in the glossary →

How Health Services is valued

What is the price implying?

~37%annual earnings growth implied by the price

At a P/E of 108.4x, the price would imply about 36.5%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.

Below the ₹1,000 cr market-cap floor used for the lists.

“Implied growth” is what the current price would require under our stated assumptions, not what we expect.

What prices imply across Health Services The market-wide Expectations lists

What changed?

  1. Sep '26Moved into the 3rd quartile of Health Services on operating margin (from the bottom quartile).
  2. Jun '26Year-on-year EPS growth turned negative.
  3. Jun '26Slipped to the bottom quartile of Health Services on EPS growth (from the top quartile).
  4. Mar '26Year-on-year EPS growth turned positive.
  5. Mar '26Fell 30% from the Jan 2026 peak to the Mar 2026 low.
  6. Mar '26Moved into the top quartile of Health Services on EPS growth (from the bottom quartile).
  7. Aug '25Regained the 2023-08 peak, 17 months after the low.
  8. Sep '24P/E crossed above the 90th percentile of its own history to date (83.0x).
Show 22 earlier events
  1. Jun '24Promoter holding fell 15.2 pts to 41.4%.
  2. Jun '24Year-on-year EPS growth turned negative.
  3. Jun '24Slipped to the bottom quartile of Health Services on ROCE (from the 3rd quartile).
  4. Jun '24Dividend payout cut from 25% to 0% of profit.
  5. Mar '24Fell 50% from the Aug 2023 peak to the Mar 2024 low.
  6. Jan '24P/E fell below the 10th percentile of its own history to date (39.3x).
  7. Nov '23Slipped to the 2nd quartile of Health Services on EPS growth (from the top quartile).
  8. Jul '23Regained the 2022-12 peak, 4 months after the low.
  9. Jun '23Revenue (TTM) reached a new high of ₹47 cr.
  10. Jun '23Moved into the 3rd quartile of Health Services on ROCE (from the bottom quartile).
  11. Mar '23Fell 39% from the Dec 2022 peak to the Mar 2023 low.
  12. Jul '22Regained the 2022-02 peak, 1 month after the low.
  13. Jun '22Fell 40% from the Feb 2022 peak to the Jun 2022 low.
  14. Jun '22Slipped to the bottom quartile of Health Services on ROCE (from the 3rd quartile).
  15. Jan '22Regained the 2021-06 peak, 3 months after the low.
  16. Jan '22P/E crossed above the 90th percentile of its own history to date (86.7x).
  17. Oct '21Fell 29% from the Jun 2021 peak to the Oct 2021 low.
  18. Jun '21Moved into the top quartile of Health Services on EPS growth (from the 2nd quartile).
  19. Jun '21Started paying a dividend (payout 66% of profit).
  20. Mar '21P/E crossed above the 90th percentile of its own history to date (80.4x).
  21. Jun '20Year-on-year EPS growth turned positive.
  22. Jun '20Regained the 2019-01 peak, 10 months after the low.

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Are profits backed by cash?

4 of 7 checks are within range, 1 near a threshold, 2 beyond a threshold.
Tap a check to see how it is measured.

Other income reliance300%Beyond threshold

Other income as a share of pre-tax profit (trailing twelve months): 300.0%. Bands: below 15%, 15% to 35%, above 35%.

Tax rate-10%Beyond threshold

Median quarterly effective tax rate over about 2.5 years: -10.3%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.

Cash conversion3.06xWithin range

Operating cash flow divided by net profit over the last three fiscal years: 3.06x (cash from operations ₹11.4 cr, net profit ₹3.7 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.

Free cash flow2 of 5 yrsNear threshold

Fiscal years with positive free cash flow in the last 5: 2. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history-1 daysWithin range

Debtor days are below the median of the previous three fiscal years by 1 days (8 vs 10). Bands: under 15 days, 15 to 45, over 45.

Capital work in progress0% of fixed assetsWithin range

Capital work-in-progress is 0% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days-37 days / 2 yrsWithin range

Days payable changed by -37 over two years. Bands: rise of up to 30 days; more than 30 days.

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

Who has been buying and selling?

  • Over 3 years, promoters trimmed 16.4 pts.
  • The number of shareholders rose from 8,314 to 9,627 (+16%) between Dec 2023 and Jun 2026.

Holdings, Jun '26

How each group changed

GroupDec '23Jun '26Change
Promoters56.6%40.1%-16.4 pts
FIIs0.0%0.0%0.0 pts
DIIs0.0%0.0%0.0 pts
Public and others43.4%59.9%+16.4 pts

Number of shareholders

9,627shareholders+16% since Dec '23
8k10k11k13k Dec '23Jun '24Dec '24Jun '25Dec '25Jun '26
Dec '23: 8,314
Mar '24: 12,502
Jun '24: 11,759
Sep '24: 12,514
Dec '24: 11,734
Mar '25: 11,508
Jun '25: 11,121
Sep '25: 10,777
Dec '25: 10,240
Mar '26: 9,939
Jun '26: 9,627
 8k10k11k13k Dec '23Dec '24Dec '25Jun '26
Dec '23: 8,314
Mar '24: 12,502
Jun '24: 11,759
Sep '24: 12,514
Dec '24: 11,734
Mar '25: 11,508
Jun '25: 11,121
Sep '25: 10,777
Dec '25: 10,240
Mar '26: 9,939
Jun '26: 9,627

Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.

This quarter's smart-money board

How rough has the ride been?

Maximum drawdown-50.4%recovered 2025-08
1-year volatility44.8%annualised

Monthly share price

₹18₹57₹96₹135 Jan '19Aug '20Mar '22Oct '23May '25Oct '26
2019-01: ₹25.50
2019-02: ₹23.55
2019-03: ₹22.05
2019-04: ₹19.60
2019-05: ₹19.50
2019-06: ₹22.15
2019-07: ₹17.60
2019-08: ₹20.00
2019-09: ₹22.25
2019-10: ₹20.55
2019-11: ₹23.35
2019-12: ₹22.65
2020-01: ₹25.65
2020-02: ₹25.55
2020-03: ₹22.90
2020-04: ₹22.50
2020-05: ₹26.20
2020-06: ₹31.50
2020-07: ₹26.25
2020-08: ₹30.75
2020-09: ₹30.15
2020-10: ₹32.05
2020-11: ₹32.80
2020-12: ₹33.15
2021-01: ₹37.05
2021-02: ₹34.60
2021-03: ₹41.00
2021-04: ₹42.75
2021-05: ₹45.20
2021-06: ₹52.85
2021-07: ₹45.20
2021-08: ₹43.65
2021-09: ₹48.70
2021-10: ₹40.15
2021-11: ₹47.95
2021-12: ₹51.90
2022-01: ₹65.00
2022-02: ₹58.65
2022-03: ₹53.00
2022-04: ₹55.60
2022-05: ₹49.55
2022-06: ₹55.00
2022-07: ₹78.35
2022-08: ₹64.85
2022-09: ₹70.15
2022-10: ₹68.35
2022-11: ₹86.60
2022-12: ₹76.55
2023-01: ₹69.75
2023-02: ₹61.70
2023-03: ₹58.60
2023-04: ₹62.05
2023-05: ₹72.45
2023-06: ₹80.55
2023-07: ₹100.30
2023-08: ₹89.80
2023-09: ₹82.90
2023-10: ₹81.50
2023-11: ₹84.80
2023-12: ₹83.40
2024-01: ₹77.05
2024-02: ₹65.10
2024-03: ₹55.65
2024-04: ₹62.35
2024-05: ₹57.05
2024-06: ₹56.38
2024-07: ₹67.63
2024-08: ₹74.64
2024-09: ₹86.28
2024-10: ₹69.71
2024-11: ₹73.83
2024-12: ₹66.64
2025-01: ₹66.25
2025-02: ₹59.30
2025-03: ₹66.99
2025-04: ₹81.22
2025-05: ₹71.90
2025-06: ₹71.16
2025-07: ₹73.43
2025-08: ₹116.84
2025-09: ₹118.49
2025-10: ₹125.03
2025-11: ₹105.65
2025-12: ₹119.24
2026-01: ₹135.27
2026-02: ₹110.19
2026-03: ₹98.22
2026-04: ₹118.87
2026-05: ₹108.57
2026-06: ₹116.82
2026-07: ₹117.51
2026-08: ₹109.08
2026-09: ₹115.89
2026-10: ₹109.15
 ₹18₹57₹96₹135 Jan '19Aug '21Mar '24Oct '26
2019-01: ₹25.50
2019-02: ₹23.55
2019-03: ₹22.05
2019-04: ₹19.60
2019-05: ₹19.50
2019-06: ₹22.15
2019-07: ₹17.60
2019-08: ₹20.00
2019-09: ₹22.25
2019-10: ₹20.55
2019-11: ₹23.35
2019-12: ₹22.65
2020-01: ₹25.65
2020-02: ₹25.55
2020-03: ₹22.90
2020-04: ₹22.50
2020-05: ₹26.20
2020-06: ₹31.50
2020-07: ₹26.25
2020-08: ₹30.75
2020-09: ₹30.15
2020-10: ₹32.05
2020-11: ₹32.80
2020-12: ₹33.15
2021-01: ₹37.05
2021-02: ₹34.60
2021-03: ₹41.00
2021-04: ₹42.75
2021-05: ₹45.20
2021-06: ₹52.85
2021-07: ₹45.20
2021-08: ₹43.65
2021-09: ₹48.70
2021-10: ₹40.15
2021-11: ₹47.95
2021-12: ₹51.90
2022-01: ₹65.00
2022-02: ₹58.65
2022-03: ₹53.00
2022-04: ₹55.60
2022-05: ₹49.55
2022-06: ₹55.00
2022-07: ₹78.35
2022-08: ₹64.85
2022-09: ₹70.15
2022-10: ₹68.35
2022-11: ₹86.60
2022-12: ₹76.55
2023-01: ₹69.75
2023-02: ₹61.70
2023-03: ₹58.60
2023-04: ₹62.05
2023-05: ₹72.45
2023-06: ₹80.55
2023-07: ₹100.30
2023-08: ₹89.80
2023-09: ₹82.90
2023-10: ₹81.50
2023-11: ₹84.80
2023-12: ₹83.40
2024-01: ₹77.05
2024-02: ₹65.10
2024-03: ₹55.65
2024-04: ₹62.35
2024-05: ₹57.05
2024-06: ₹56.38
2024-07: ₹67.63
2024-08: ₹74.64
2024-09: ₹86.28
2024-10: ₹69.71
2024-11: ₹73.83
2024-12: ₹66.64
2025-01: ₹66.25
2025-02: ₹59.30
2025-03: ₹66.99
2025-04: ₹81.22
2025-05: ₹71.90
2025-06: ₹71.16
2025-07: ₹73.43
2025-08: ₹116.84
2025-09: ₹118.49
2025-10: ₹125.03
2025-11: ₹105.65
2025-12: ₹119.24
2026-01: ₹135.27
2026-02: ₹110.19
2026-03: ₹98.22
2026-04: ₹118.87
2026-05: ₹108.57
2026-06: ₹116.82
2026-07: ₹117.51
2026-08: ₹109.08
2026-09: ₹115.89
2026-10: ₹109.15

Last 90 trading days

₹107₹114₹121₹128 Jun 23Jul 20Aug 13Sep 8Oct 6Oct 30
2026-06-23: ₹124.21
2026-06-25: ₹125.02
2026-06-30: ₹116.82
2026-07-02: ₹125.59
2026-07-06: ₹122.17
2026-07-08: ₹118.56
2026-07-10: ₹118.28
2026-07-14: ₹122.97
2026-07-16: ₹122.57
2026-07-20: ₹121.42
2026-07-22: ₹118.98
2026-07-24: ₹119.06
2026-07-28: ₹118.57
2026-07-30: ₹118.47
2026-08-03: ₹117.46
2026-08-05: ₹117.83
2026-08-07: ₹118.82
2026-08-11: ₹119.78
2026-08-13: ₹116.61
2026-08-17: ₹115.83
2026-08-19: ₹115.51
2026-08-21: ₹115.60
2026-08-25: ₹113.99
2026-08-27: ₹112.63
2026-08-31: ₹109.08
2026-09-02: ₹107.98
2026-09-04: ₹109.43
2026-09-08: ₹110.66
2026-09-10: ₹111.62
2026-09-15: ₹110.59
2026-09-17: ₹113.12
2026-09-21: ₹114.68
2026-09-23: ₹115.24
2026-09-25: ₹115.07
2026-09-29: ₹113.20
2026-10-01: ₹115.68
2026-10-06: ₹115.37
2026-10-08: ₹113.94
2026-10-12: ₹107.13
2026-10-14: ₹111.85
2026-10-16: ₹114.36
2026-10-21: ₹110.33
2026-10-23: ₹112.40
2026-10-27: ₹109.65
2026-10-29: ₹110.00
2026-10-30: ₹109.15
 ₹107₹114₹121₹128 Jun 23Aug 5Sep 17Oct 30
2026-06-23: ₹124.21
2026-06-25: ₹125.02
2026-06-30: ₹116.82
2026-07-02: ₹125.59
2026-07-06: ₹122.17
2026-07-08: ₹118.56
2026-07-10: ₹118.28
2026-07-14: ₹122.97
2026-07-16: ₹122.57
2026-07-20: ₹121.42
2026-07-22: ₹118.98
2026-07-24: ₹119.06
2026-07-28: ₹118.57
2026-07-30: ₹118.47
2026-08-03: ₹117.46
2026-08-05: ₹117.83
2026-08-07: ₹118.82
2026-08-11: ₹119.78
2026-08-13: ₹116.61
2026-08-17: ₹115.83
2026-08-19: ₹115.51
2026-08-21: ₹115.60
2026-08-25: ₹113.99
2026-08-27: ₹112.63
2026-08-31: ₹109.08
2026-09-02: ₹107.98
2026-09-04: ₹109.43
2026-09-08: ₹110.66
2026-09-10: ₹111.62
2026-09-15: ₹110.59
2026-09-17: ₹113.12
2026-09-21: ₹114.68
2026-09-23: ₹115.24
2026-09-25: ₹115.07
2026-09-29: ₹113.20
2026-10-01: ₹115.68
2026-10-06: ₹115.37
2026-10-08: ₹113.94
2026-10-12: ₹107.13
2026-10-14: ₹111.85
2026-10-16: ₹114.36
2026-10-21: ₹110.33
2026-10-23: ₹112.40
2026-10-27: ₹109.65
2026-10-29: ₹110.00
2026-10-30: ₹109.15

Drawdown from peak

0% -23% -47% Jan '19Dec '22Oct '26 0% -23% -47% Jan '19Dec '22Oct '26
Largest drawdowns

-50.4% (2023-08 peak to 2024-03 low, recovered 2025-08)

-43.0% (2019-01 peak to 2019-08 low, recovered 2020-06)

-40.3% (2022-02 peak to 2022-06 low, recovered 2022-07)

Where does it rank among Health Services peers?

Each cell is the company's percentile rank among its Health Services peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

ROCE
Op. margin
Revenue growth
EPS growth
Debt/equity ↓
Cash cycle ↓
P/E ↓
12M momentum
Nov '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Oct '26
Lower rank Higher rank

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Health Services sector page Watch it move against Health Services in the Observatory

What happened next to similar setups

−11.1%typical 12-month return vs the marketNot meaningfully different from the base rate
  • We found 50 past situations where a non-financial company looked like LOTUS EYE HOSPITAL AND INS LTD today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
  • Over the following 12 months the middle half of them returned −34% to +20% vs the market, against −6% for all non-financial companies in the same months.
  • The gap against the base rate (−4.9%, 80% range −13.7% to +2.5%) is within what chance and overlapping periods produce.

Where the 50 outcomes landed

−100%−50%0%+50%+100%
AKASH · Mar 2021: −75.9% vs market
VAKRANGEE · Apr 2024: −63.4% vs market
BROOKS · Sep 2025: −58.6% vs market
VIRINCHI · Aug 2025: −51.3% vs market
RUCHINFRA · Apr 2024: −49.2% vs market
NEOGEN · Nov 2024: −48.3% vs market
SINTERCOM · Mar 2025: −42.7% vs market
BHANDARI · Jul 2025: −41.4% vs market
EIFFL · Mar 2020: −41.1% vs market
BPL · Aug 2025: −39.1% vs market
AHLEAST · Feb 2020: −38.0% vs market
PPAP · Jul 2021: −34.6% vs market
BIOFILCHEM · Mar 2024: −34.5% vs market
PILITA · Dec 2020: −33.8% vs market
ATULAUTO · Jun 2024: −28.2% vs market
SAPPHIRE · Sep 2025: −28.1% vs market
SHALBY · Jul 2025: −26.9% vs market
S&SPOWER · Sep 2025: −24.7% vs market
TOKYOPLAST · Jul 2021: −22.9% vs market
TDPOWERSYS · Jan 2020: −19.7% vs market
MAHEPC · May 2025: −18.8% vs market
MAXESTATES · May 2025: −17.2% vs market
IFBIND · Apr 2024: −17.1% vs market
MAANALU · Jun 2024: −16.7% vs market
PROZONER · May 2020: −13.6% vs market
ADVANIHOTR · Jun 2020: −8.7% vs market
DMCC · Dec 2023: −7.3% vs market
ASHIANA · Feb 2022: −7.2% vs market
BHAGCHEM · Sep 2025: −7.1% vs market
SOLARA · Aug 2025: −4.0% vs market
DPSCLTD · Jul 2023: +0.2% vs market
BYKE · Feb 2024: +0.4% vs market
5PAISA · May 2023: +0.9% vs market
DIAMONDYD · Jul 2022: +1.4% vs market
SAGCEM · Jan 2020: +2.2% vs market
SNOWMAN · May 2023: +13.2% vs market
SOFTTECH · Jun 2025: +15.5% vs market
DREDGECORP · Dec 2022: +21.5% vs market
RAJTV · Jan 2024: +23.1% vs market
RATEGAIN · May 2023: +28.9% vs market
SHILPAMED · Jul 2024: +38.4% vs market
VALIANTORG · Sep 2025: +38.7% vs market
GOLDTECH · Apr 2023: +39.1% vs market
INDOWIND · Jun 2021: +73.0% vs market
TATVA · Sep 2025: +75.6% vs market
ANANTRAJ · Mar 2022: +95.2% vs market
YASHO · Aug 2025: +115.5% vs market
URJA · Apr 2020: +142.4% vs market
PREMEXPLN · Mar 2023: +153.5% vs market
ZENTEC · Sep 2022: +239.0% vs market
Similar setups −11.1%All companies −6.2%← worse than the marketbetter than the market →

Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 4 beyond the range shown, drawn at the edge

Similar setups' median
−11.1%
All companies' median
−6.2%
Beat the market
40% vs 43%

50 past situations · 50 companies · 33 months · 2020–2025

The closest matches

CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
SINTERCOM
Producer Manufacturing		 Mar 2025 334x5% −1%−27% −43%
SOFTTECH
Technology Services		 Jun 2025 377x4% +4%−32% +16%
SNOWMAN
Commercial Services		 May 2023 376x3% +18%−13% +13%
RAJTV
Consumer Services		 Jan 2024 306x3% +40%−7% +23%
EIFFL
Consumer Non-Durables		 Mar 2020 209x4% −39%−44% −41%
Show the other 3 matches
CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
TDPOWERSYS
Producer Manufacturing		 Jan 2020 136x3% +7%−18% −20%
ASHIANA
Finance		 Feb 2022 920x0% +33%−24% −7%
TOKYOPLAST
Producer Manufacturing		 Jul 2021 834x1% +86%−3% −23%
How reliable is this?

Matched on P/E, P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: 12-month momentum, drawdown from 12-month high and ROCE. One match per company and at most 7 from any one month.

Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.

How this is built

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to LOTUS EYE HOSPITAL AND INS LTD. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Methodology

How historical analogs are built

Data as of 2026-10-30. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

FeatureWeightNon-financialFinancial
P/E1yesyes
P/S1yes—
P/B1—yes
ROCE1yes—
operating margin1yes—
ROE1—yes
debt/equity0.75yes—
interest cover0.5yes—
revenue growth0.75yesyes
12-month momentum1yesyes
drawdown from 12-month high0.75yesyes
size0.75yesyes
volatility0.5yesyes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

  • One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
  • Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
  • Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
  • Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
  • Pools: non-financial: 97,430 company-months from 2000 companies; financial: 5,632 company-months from 106 companies. 2240 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.
Monthly history (94 months)
MonthP/ERevenue (TTM)ROEROCEDebt / Equity
2026-101559.3x₹57 cr0.2%1.4%0.3x
2026-091655.6x₹57 cr0.2%1.4%0.3x
2026-082727.0x₹54 cr0.1%1.4%0.3x
2026-072937.8x₹54 cr0.1%1.4%0.3x
2026-062920.5x₹54 cr0.1%1.4%0.3x
2026-05350.2x₹52 cr1.1%3.0%0.1x
2026-04383.5x₹52 cr1.1%3.0%0.1x
2026-03316.8x₹52 cr1.1%3.0%0.1x
2026-02344.3x₹50 cr1.1%3.0%0.1x
2026-01422.7x₹50 cr1.1%3.0%0.1x
2025-12372.6x₹50 cr1.1%3.0%0.1x
2025-11340.8x₹50 cr1.1%3.0%0.1x
2025-10403.3x₹50 cr1.1%3.0%0.1x
2025-09382.2x₹50 cr1.1%3.0%0.1x
2025-08333.8x₹50 cr1.2%3.0%0.1x
2025-07209.8x₹50 cr1.2%3.0%0.1x
2025-06203.3x₹50 cr1.2%3.0%0.1x
2025-05299.6x₹49 cr0.8%7.1%0.0x
2025-04338.4x₹49 cr0.8%7.1%0.0x
2025-03279.1x₹49 cr0.8%7.1%0.0x
2025-0287.2x₹49 cr2.4%7.1%0.0x
2025-0197.4x₹49 cr2.4%7.1%0.0x
2024-1298.0x₹49 cr2.4%7.1%0.0x
2024-1171.0x₹49 cr3.6%7.1%0.0x
2024-1067.0x₹49 cr3.6%7.1%0.0x
2024-0983.0x₹49 cr3.6%7.1%0.0x
2024-0853.3x₹48 cr4.9%7.1%0.0x
2024-0748.3x₹48 cr4.9%7.1%0.0x
2024-0640.3x₹48 cr4.9%7.1%0.0x
2024-0529.1x₹47 cr7.1%10.3%0.0x
2024-0431.8x₹47 cr7.1%10.3%0.0x
2024-0328.4x₹47 cr7.1%10.3%0.0x
2024-0233.2x₹47 cr7.1%10.3%0.0x
2024-0139.3x₹47 cr7.1%10.3%0.0x
2023-1242.6x₹47 cr7.1%10.3%0.0x
2023-1143.3x₹47 cr7.1%10.3%0.0x
2023-1041.6x₹47 cr7.1%10.3%0.0x
2023-0942.3x₹47 cr7.1%10.3%0.0x
2023-0845.8x₹47 cr7.1%10.3%0.0x
2023-0751.2x₹47 cr7.1%10.3%0.0x
2023-0641.1x₹47 cr7.1%10.3%0.0x
2023-0550.7x₹39 cr5.5%7.9%0.0x
2023-0443.4x₹39 cr5.5%7.9%0.0x
2023-0341.0x₹39 cr5.5%7.9%0.0x
2023-0243.1x₹39 cr5.5%7.9%0.0x
2023-0148.8x₹39 cr5.5%7.9%0.0x
2022-1253.5x₹39 cr5.5%7.9%0.0x
2022-1160.6x₹39 cr5.5%7.9%0.0x
2022-1047.8x₹39 cr5.5%7.9%0.0x
2022-0949.1x₹39 cr5.5%7.9%0.0x
2022-0845.3x₹39 cr5.5%7.9%0.0x
2022-0754.8x₹39 cr5.5%7.9%0.0x
2022-0638.5x₹39 cr5.5%7.9%0.0x
2022-0566.1x₹32 cr3.0%3.9%0.0x
2022-0474.1x₹32 cr3.0%3.9%0.0x
2022-0370.7x₹32 cr3.0%3.9%0.0x
2022-0278.2x₹32 cr3.0%3.9%0.0x
2022-0186.7x₹32 cr3.0%3.9%0.0x
2021-1269.2x₹32 cr3.0%3.9%0.0x
2021-1163.9x₹32 cr3.0%3.9%0.0x
2021-1053.5x₹32 cr3.0%3.9%0.0x
2021-0964.9x₹32 cr3.0%3.9%0.0x
2021-0858.2x₹32 cr3.0%3.9%0.0x
2021-0760.3x₹32 cr3.0%3.9%0.0x
2021-0670.5x₹32 cr3.0%3.9%0.0x
2021-0588.6x₹41 cr2.1%4.7%0.0x
2021-0483.8x₹41 cr2.1%4.7%0.0x
2021-0380.4x₹41 cr2.1%4.7%0.0x
2021-0267.8x₹41 cr2.1%4.7%0.0x
2021-0172.6x₹41 cr2.1%4.7%0.0x
2020-1265.0x₹41 cr2.1%4.7%0.0x
2020-1164.3x₹41 cr2.1%4.7%0.0x
2020-1062.8x₹41 cr2.1%4.7%0.0x
2020-0959.1x₹41 cr2.1%4.7%0.0x
2020-0860.3x₹41 cr2.1%4.7%0.0x
2020-0751.5x₹41 cr2.1%4.7%0.0x
2020-0661.8x₹41 cr2.1%4.7%0.0x
2020-0577.1x₹38 cr1.4%1.7%0.0x
2020-0466.2x₹38 cr1.4%1.7%0.0x
2020-0367.4x₹38 cr1.4%1.7%0.0x
2020-0275.1x₹38 cr1.4%1.7%0.0x
2020-0175.4x₹38 cr1.4%1.7%0.0x
2019-1266.6x₹38 cr1.4%1.7%0.0x
2019-1168.7x₹38 cr1.4%1.7%0.0x
2019-1060.4x₹38 cr1.4%1.7%0.0x
2019-0965.4x₹38 cr1.4%1.7%0.0x
2019-0858.8x₹38 cr1.4%1.7%0.0x
2019-0751.8x₹38 cr1.4%1.7%0.0x
2019-0665.1x₹38 cr1.4%1.7%0.0x
2019-0523.2x₹38 cr3.5%3.6%0.0x
2019-0423.3x₹38 cr3.5%3.6%0.0x
2019-0326.3x₹38 cr3.5%3.6%0.0x
2019-0228.0x₹38 cr3.5%3.6%0.0x
2019-0130.4x₹38 cr3.5%3.6%0.0x

Methodology and data notes

Methodology

Methodology and data notes

All figures come from public exchange prices and screener.in financial statements. Quarterly and annual results are shown from 60 days after the period end, so a month never uses a result before it would plausibly have been published. Statements are the latest versions, which may include later restatements.

Sector medians, percentiles and indices use today's listed companies in the sector (survivorship bias). Prices are adjusted for splits and bonus issues; around a corporate action the fundamentals may lag the price by up to a month, and affected sections are hidden.

The return decomposition uses price = P/E × net profit ÷ share count. The reverse DCF uses a fixed 12% cost of equity, a 10-year horizon and a 15x terminal P/E, and is an illustration only. Events, flags and twins follow fixed rules and thresholds described next to each section.

Feedback